Navegando por Palavras-chave "Prescrições"

Agora exibindo 1 - 2 de 2
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Avaliação da orientação médica sobre os efeitos colaterais de benzodiazepínicos
    (Associação Brasileira de Psiquiatria - ABP, 2004-03-01) Auchewski, Luciana; Andreatini, Roberto; Galduróz, José Carlos Fernandes [UNIFESP]; Lacerda, Roseli Boerngen de; Universidade Federal do Paraná Departamento de Farmacologia; Universidade Federal de São Paulo (UNIFESP); Centro Brasileiro de Informações sobre Drogas Psicotrópicas
    OBJECTIVES: Benzodiazepines are among the most prescribed drugs indicated as anxiolytics, hypnotics, myorrelaxants or antiepileptics. Their main side effects are: reduced psychomotor activities, interaction to other drugs, like alcohol, and the development of dependence. In the present study it was evaluated the quality of the medical directions given to patients about those side effects. METHODS: One hundred and twenty patients (39 men and 81 women), mean age of 48 years old, who visited pharmacies in Curitiba to buy prescribed benzodiazepines, were interviewed by an open or directive questionnaire designed to obtain the medical directions about benzodiazepines side effects. RESULTS: Directions about the three main benzodiazepines side effects were observed only in 13% of the patients, 27% had received at least two and 40% only one, while 19% reported no directions. It suggested that the medical orientation was precarious and its quality was not influenced by the patients' educational level, the kind of medical attendance or the specialty of the physician. The main orientation cited was ''don't drink'' (85%), followed by ''don't drive or operate machines'' (46%), while few orientations about the risk to develop dependence on benzodiazepines was observed (31%). CONCLUSION: This suggests that physicians were worried about the alcohol interaction risk, which can be dangerous for the patients. The high number of patients using benzodiazepines continuously for more than one year (61%), the unsuccessfully attempt to stop using BZD (94%) and the poor information about the duration of the treatment (22%) were all related to the low medical worry about dependence on benzodiazepines.
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Metilfenidato: influência da notificação de receita A (cor amarela) sobre a prática de prescrição por médicos brasileiros
    (Faculdade de Medicina da Universidade de São Paulo, 2003-01-01) Carlini, Elisaldo Araujo [UNIFESP]; Nappo, Solange Aparecida [UNIFESP]; Nogueira, Vagner; Naylor, Fernando G. M.; Universidade Federal de São Paulo (UNIFESP); Novartis Biociências
    Four hundred and sixty three brazilian neurologists and 411 brazilian psychiatrists answered a questionnaire aimed at to obtain information on the prescription of methylphenidate for the treatment of the Attention Deficit and Hyperactivity Disorder. The majority of the doctors reported the erratic occurrence of a few non serious adverse reactions such as headache, weight loss, inapetence, hyperexcitability and tachycardia. On the other hand, only six doctors reported cases that cold raise a suspicion of drug dependence, although none of these six cases satisfied the ICD-10 criteria for dependence. The vast majority of the medical doctors manifested the opinion that the especial prescriptions the Notifications A of yellow color, the same used for opiates also, as demanded by the Brazilian Health Authorities, is inadequate as it raises misconceptions in relation to the real patient disease and frightens the parents and relatives. The doctors also claimed the such especial prescription form encumbers the prescription of the medicament making methylphenidate the second choice for the treatment and, for this reason, less available in pharmacies and drugstores. As a consequence the adherence to the treatment is more difficult to attain. The neurologists and psychiatrists agree that a certain control over methylphenidate is necessary, but as it is prescribed mostly by specialists and does not possess an evident abuse potential, the Prescription Notification B, of blue color, would be enough for efficient control. In fact, according to the doctors, the scheduling in Brazil of methylphenidate in the same list as the amphetamines and dronabinol (the active principle of Cannabis sativa) should be reviewed.